Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
outcomes of chop versus choep epoch in aggressive adult t cell leukemia lymphoma an international cohort analysis
Original title: “Outcomes of CHOP versus CHOEP/EPOCH in aggressive adult T-cell leukemia/lymphoma: an international cohort analysis.”
prognostic impact of morphological lymphocyte counts on aggressive adult t cell leukemia lymphoma japan atl nationwide registry analysis
Original title: “Prognostic impact of morphological lymphocyte counts on aggressive adult T-cell leukemia/lymphoma: Japan ATL nationwide registry analysis.”
adult t cell leukemia lymphoma and targeted maternal screening
Original title: “Adult T-Cell Leukemia/Lymphoma and Targeted Maternal Screening.”
dinaciclib reduces mcl 1 levels and triggers apoptosis in adult t cell leukemia lymphoma
Original title: “Dinaciclib reduces MCL-1 levels and triggers apoptosis in adult T-cell leukemia/lymphoma.”